Zobrazeno 1 - 10
of 30
pro vyhledávání: '"I. Russel Lee"'
Autor:
Xuan Ying Poh, I. Russel Lee, Chee Wah Tan, Jean-Marc Chavatte, Siew Wai Fong, Yun Shan Goh, Angeline Rouers, Nathan Wong, Anthony Torres-Ruesta, Shirley Y.Y. Mah, Aileen Y.Y. Yeoh, Mihir Gandhi, Nabilah Rahman, Yi Qing Chin, J. Jonathan Lim, Terence J.K. Yoong, Suma Rao, Po Ying Chia, Sean W.X. Ong, Tau Hong Lee, Sapna P. Sadarangani, Ray J.H. Lin, Daniel R.X. Lim, Wanni Chia, Laurent Renia, Ee Chee Ren, Raymond T.P. Lin, David C. Lye, Lin-Fa Wang, Lisa F.P. Ng, Barnaby E. Young
Publikováno v:
EBioMedicine, Vol 107, Iss , Pp 105275- (2024)
Summary: Background: Understanding how SARS-CoV-2 breakthrough infections impacts the breadth of immune responses against existing and pre-emergent SARS-CoV-2 strains is needed to develop an evidence-based long-term immunisation strategy. Methods: We
Externí odkaz:
https://doaj.org/article/4ec8750f0a144a5283fffeb6b9790a82
Autor:
Yun Shan Goh, Siew‐Wai Fong, Pei Xiang Hor, Chiew Yee Loh, Matthew Zirui Tay, Bei Wang, Siti Nazihah Mohd Salleh, Eve Zi Xian Ngoh, Raphael Tze Chuen Lee, Xuan Ying Poh, I. Russel Lee, Suma Rao, Po Ying Chia, Sebastian Maurer-Stroh, Cheng-I Wang, Yee‐Sin Leo, David C. Lye, Barnaby Edward Young, Lisa F.P. Ng, Laurent Renia
Publikováno v:
International Journal of Infectious Diseases, Vol 146, Iss , Pp 107147- (2024)
Objectives: The emergence of new SARS-CoV-2 variants has led to the development of Omicron-targeting bivalent mRNA vaccines. It is crucial to understand how bivalent vaccines may improve antibody responses against new variants. Methods: A total of 10
Externí odkaz:
https://doaj.org/article/10a40254e10745f0b29910119928a1bb
Autor:
I. Russel Lee, Steven Y. C. Tong, Joshua S. Davis, David L. Paterson, Sharifah F. Syed-Omar, Kwong Ran Peck, Doo Ryeon Chung, Graham S. Cooke, Eshele Anak Libau, Siti-Nabilah B. A. Rahman, Mihir P. Gandhi, Luming Shi, Shuwei Zheng, Jenna Chaung, Seow Yen Tan, Shirin Kalimuddin, Sophia Archuleta, David C. Lye
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-18 (2022)
Abstract Background The incidence of Gram-negative bacteraemia is rising globally and remains a major cause of morbidity and mortality. The majority of patients with Gram-negative bacteraemia initially receive intravenous (IV) antibiotic therapy. How
Externí odkaz:
https://doaj.org/article/253c69f328114ff886045878b6aee562
Autor:
Xuan Ying Poh, I. Russel Lee, Clarissa Lim, Jefanie Teo, Suma Rao, Po Ying Chia, Sean W. X. Ong, Tau Hong Lee, Ray J. H. Lin, Lisa F. P. Ng, Ee Chee Ren, Raymond T. P. Lin, Lin-Fa Wang, Laurent Renia, David Chien Lye, Barnaby E. Young
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-13 (2022)
Abstract Background Over 2021, COVID-19 vaccination programs worldwide focused on raising population immunity through the primary COVID-19 vaccine series. In Singapore, two mRNA vaccines (BNT162b2 and mRNA-1273) and the inactivated vaccine CoronaVac
Externí odkaz:
https://doaj.org/article/c98caff7101945acb1f35e219873ed4a
Autor:
James S. Molton, I. Russel Lee, Denis Bertrand, Ying Ding, Shirin Kalimuddin, David C. Lye, Niranjan Nagarajan, Yunn-Hwen Gan, Sophia Archuleta
Publikováno v:
International Journal of Infectious Diseases, Vol 107, Iss , Pp 1-4 (2021)
Objectives: Hypermucoviscous Klebsiella pneumoniae is an emerging cause of community-acquired liver abscess. The aim of this study was to investigate whether hypermucoviscous strains could be shared among households. Methods: The clinical K. pneumoni
Externí odkaz:
https://doaj.org/article/c6458c52c7904e3b89652ab5001be7d1
Autor:
I. Russel Lee, Ethel Sng, Kok-Onn Lee, James S. Molton, Monica Chan, Shirin Kalimuddin, Ezlyn Izharuddin, David C. Lye, Sophia Archuleta, Yunn-Hwen Gan
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 7 (2017)
The major risk factor for Klebsiella liver abscess (KLA) is type 2 diabetes mellitus (DM), but the immunological mechanisms involved in the increased susceptibility are poorly defined. We investigated the responses of neutrophils and peripheral blood
Externí odkaz:
https://doaj.org/article/400ea05b9b074d99aa2557b89f5087cc
Autor:
Carl A. Morrow, I. Russel Lee, Eve W. L. Chow, Kate L. Ormerod, Anita Goldinger, Edmond J. Byrnes, Kirsten Nielsen, Joseph Heitman, Horst Joachim Schirra, James A. Fraser
Publikováno v:
mBio, Vol 3, Iss 2 (2012)
ABSTRACT The accumulation of genomic structural variation between closely related populations over time can lead to reproductive isolation and speciation. The fungal pathogen Cryptococcus is thought to have recently diversified, forming a species com
Externí odkaz:
https://doaj.org/article/7d4a2cf716e445d3a54b242745c8e8b6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xuan Ying Poh, Chee Wah Tan, I Russel Lee, Jean-Marc Chavatte, Siew-Wai Fong, Tessa Prince, Catherine Hartley, Aileen Y Y Yeoh, Suma Rao, Po Ying Chia, Sean W X Ong, Tau Hong Lee, Sapna P Sadarangani, Ray J H Lin, Clarissa Lim, Jefanie Teo, Daniel R X Lim, Wanni Chia, Julian A Hiscox, Lisa F P Ng, Ee Chee Ren, Raymond T P Lin, Laurent Renia, David Chien Lye, Lin-Fa Wang, Barnaby E Young
Publikováno v:
Clinical Infectious Diseases. 75:2088-2096
Background Waning antibody levels post-vaccination and the emergence of variants of concern (VOCs) capable of evading protective immunity have raised the need for booster vaccinations. However, which combination of coronavirus disease 2019 (COVID-19)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::598d63ca8552faa30c2e25c059048bf4
https://doi.org/10.1093/cid/ciac345
https://doi.org/10.1093/cid/ciac345
Autor:
I. Russel Lee, Tun-Linn Thein, David C. Lye, Li Wei Ang, Christina Titin, Ying Ding, Shilpa Mukherjee, Chwee Fang Bok, Sophia Archuleta, Jonathan J Lim, Shirin Kalimuddin
Publikováno v:
Journal of Antimicrobial Chemotherapy. 76:1303-1310
BackgroundCeftriaxone is the preferred treatment for bacteraemia caused by non-MDR (antibiotic-susceptible) Klebsiella pneumoniae. Excessive and widespread ceftriaxone use creates selection pressure for ESBLs. Cefazolin is an alternative, although th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08a8bf05255904021c3bb547c1d49a56
https://doi.org/10.1093/jac/dkab009
https://doi.org/10.1093/jac/dkab009